Variability in total serum IgE over 1 year in severe asthmatics

BACKGROUND: Immunoglobulin E (IgE) is the treatment target of omalizumab, a monoclonal antibody indicated in the treatment of severe allergic asthma. Long-term variability of serum total IgE (sIgE(tot)) in asthmatics remains poorly documented. METHODS: In this prospective study, sIgE(tot) levels wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Louis, Renaud, Pilette, Charles, Michel, Olivier, Michils, Alain, Brusselle, Guy, Poskin, Antoine, Van Schoor, Jan, Denhaerynck, Kris, Vancayzeele, Stefaan, Abraham, Ivo, Gurdain, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441212/
https://www.ncbi.nlm.nih.gov/pubmed/30976287
http://dx.doi.org/10.1186/s13223-019-0331-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441212/
https://www.ncbi.nlm.nih.gov/pubmed/30976287
http://dx.doi.org/10.1186/s13223-019-0331-8

Ejemplares similares